OTC Medication Information: Jabon Shelo Nabel Con Alantoina Baba De Caracol

JABON SHELO NABEL CON ALANTOINA BABA DE CARACOL- allantoin soap
Corporativo Serysi S de R L de C V

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Active Ingredient

Ingrediente Activo

Ingrediente Inactivo

No usar en caso de

KROC

Purpose

Indicaciones

advertencias

Administración

Display Panel

Panel de exhibición

JABON SHELO NABEL CON ALANTOINA BABA DE CARACOL
allantoin soap
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:71424-7713
Route of Administration CUTANEOUS, TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ALLANTOIN (ALLANTOIN) ALLANTOIN 5 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
GLYCERIN
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:71424-7713-1 99 g in 1 PACKAGE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part347 10/02/2017
Labeler — Corporativo Serysi S de R L de C V (816628390)
Registrant — Corporativo Serysi S de R L de C V (816628390)

Revised: 10/2019 Corporativo Serysi S de R L de C V

Our database comes directly from the FDA’s central repository of drug labels and package inserts under the Structured Product Labeling standard. OTCLabels.com provides the full over the counter products subset of the FDA’s repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. OTCLabels.com provides the full over the counter products subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.